Home
Neopharmed Gentili S.p.A.

Neopharmed Gentili S.p.A. Market Share Analysis for August 2026

NEO SOSTENIBILITÀ Neopharmed si impegna a essere protagonista nell’ambito della salute con una strategia imprenditoriale sostenibile focalizzata nello sviluppo di soluzioni farmaceutiche innovative che elevino la qualità della vita delle persone. Viviamo in un’epoca di grandi cambiamenti. Il pianeta è sfruttato oltre i suoi limiti e i suoi equilibri sono in continua trasformazione. Stiamo cambiando […]

Industry: N/A

Domainneogen.it

Year Founded2011

Employees201 - 500

Annual Revenue$5M - $10M

Neopharmed Gentili S.p.A.

Neopharmed Gentili S.p.A. (including company regionals)

neogen.it

See more website traffic and engagement information

Neopharmed Gentili S.p.A. Revenue up to August 2026 is 5M - 10M

revenue generated by Neopharmed Gentili S.p.A. top domains

Neopharmed Gentili S.p.A. top domains revenue over 3 years

Revenue for Neopharmed Gentili S.p.A. top domains

neogen.it5M - 10M

See more with Sales Intelligence

Total visits to Neopharmed Gentili S.p.A.'s top domains

Understand Neopharmed Gentili S.p.A. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neogen.it1.7K

See more with Sales Intelligence

Avg. visit duration in Neopharmed Gentili S.p.A.'s top domains

Analyze Neopharmed Gentili S.p.A. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neogen.it00:00:44

See more with Sales Intelligence

Avg. pageviews on Neopharmed Gentili S.p.A.'s top domains

See how Neopharmed Gentili S.p.A. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neogen.it2.00

See more with Sales Intelligence

Neopharmed Gentili S.p.A. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Neopharmed Gentili S.p.A.

These are the website technologies, by industry, used by Neopharmed Gentili S.p.A. top domains

Social (5)

Instagram

Widget (5)

Twemoji

Mobile (3)

Meta Viewport

Audio Video Media (2)

Vimeo

More Technologies

7

See all

News & Signals from Neopharmed Gentili S.p.A.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeopharmed Gentili S.p.A. receives financing of $1.02B.Neopharmed Gentili prices €890m 7NC1 snr sec FRN

NewsBioCryst Pharmaceuticals, Inc. sells assets to Neopharmed Gentili S.p.A. in the amount of $260M.The transaction extends a relationship established in 2025, when Neopharmed Gentili acquired BioCryst's European Orladeyo business - including the commercial infrastructure built to support that product across the region - for approximately USD 260 million.